Nina Khanna
  • Infection Biology Laboratory, Department of Biomedicine and Division of Infectious Diseases and Hospital Epidemiology, University and University Hospital of Basel, Switzerland
Research focus
  • Microbiology
Personal information


MD in infectious diseases and hospital epidemiology and internal medicine, University of Basel, CH, 2001

Current position

Research group leader and staff physician in the Division of Infectious Diseases and Hospital Epidemiology and at the Infection Biology Laboratory, Department of Biomedicine, University Hospital and University of Basel, Switzerland

Publications (since 2005)

  1. Cosgrove, C., Ussher, J. E., Rauch, A., Gartner, K., Kurioka, A., Hühn, M. H., Adelmann, K., Kang, Y.-H., Fergusson, J. R. and Simmonds, P. (2013). Early and nonreversible decrease of CD161++/MAIT cells in HIV infection. Blood 121(6): 951-961.
  2. Chevrier, I., Sagué, J. L., Brunetto, P. S., Khanna, N., Rajacic, Z. and Fromm, K. M. (2013). Rings, chains and helices: new antimicrobial silver coordination compounds with (iso-) nicotinic acid derivatives. Dalton Transactions 42(1): 217-231.
  3. Nowakowska, J., Griesser, H. J., Textor, M., Landmann, R. and Khanna, N. (2013). Antimicrobial Properties of 8-Hydroxyserrulat-14-en-19-oic Acid for Treatment of Implant-Associated Infections. Antimicrob Agents Chemother 57(1): 333-342.
  4. Egli, A., Bucher, C., Dumoulin, A., Stern, M., Buser, A., Bubendorf, L., Gregor, M., Servida, P., Sommer, G. and Bremerich, J. (2012). Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation. Infection 40(6): 677-684.
  5. Berger, C., Boggian, K., Cusini, A., van Delden, C., Garzoni, C., Hirsch, H. H., Khanna, N., Koller, M., Manuel, O. and Meylan, P. (2012). Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant 17(6): 581-585.
  6. Viscidi, R. P., Khanna, N., Tan, C. S., Li, X., Jacobson, L., Clifford, D. B., Nath, A., Margolick, J. B., Shah, K. V. and Hirsch, H. H. (2011). JC virus antibody and viremia as predictors of progressive multifocal leukoencephalopathy in human immunodeficiency virus-1–infected individuals. Clinical infectious diseases 53(7): 711-715.
  7. Stuehler, C., Khanna, N., Bozza, S., Zelante, T., Moretti, S., Kruhm, M., Lurati, S., Conrad, B., Worschech, E., Stevanovic, S., Krappmann, S., Einsele, H., Latge, J. P., Loeffler, J., Romani, L. and Topp, M. S. (2011). Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 117(22): 5881-5891.
  8. Khanna, N., Stuehler, C., Conrad, B., Lurati, S., Krappmann, S., Einsele, H., Berges, C. and Topp, M. S. (2011). Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154. Blood 118(4): 1121-1131.
  9. John, A.-K., Schmaler, M., Khanna, N. and Landmann, R. (2011). Reversible daptomycin tolerance of adherent staphylococci in an implant infection model. Antimicrob Agents Chemother 55(7): 3510-3516.
  10. Cantoni, N., Hirsch, H. H., Khanna, N., Gerull, S., Buser, A., Bucher, C., Halter, J., Heim, D., Tichelli, A., Gratwohl, A. and Stern, M. (2010). Evidence for a bidirectional relationship between cytomegalovirus replication and acute graft-versus-host disease. Biol Blood Marrow Transplant 16(9): 1309-1314.
  11. Battegay. M., Khanna, N. and Kaufmann, G.R. (2009). CD4 T-cell recovery is independent of the class of antiretroviral therapy Revisited. Clinical infectious diseases 48(3):370-372.
  12. Khanna, N., Steffen, I., Studt, J. D., Schreiber, A., Lehmann, T., Weisser, M., Fluckiger, U., Gratwohl, A., Halter, J. and Hirsch, H. H. (2009). Outcome of influenza infections in outpatients after allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 11(2): 100-105.
  13. Khanna, N., Wolbers, M., Mueller, N. J., Garzoni, C., Du Pasquier, R. A., Fux, C. A., Vernazza, P., Bernasconi, E., Viscidi, R. and Battegay, M. (2009). JC virus-specific immune responses in human immunodeficiency virus type 1 patients with progressive multifocal leukoencephalopathy. J Virol 83(9): 4404-4411.
  14. Khanna, N., Elzi, L., Mueller, N. J., Garzoni, C., Cavassini, M., Fux, C. A., Vernazza, P., Bernasconi, E., Battegay, M. and Hirsch, H. H. (2009). Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clinical infectious diseases 48(10): 1459-1466.
  15. Khanna, N., Opravil, M., Furrer, H., Cavassini, M., Vernazza, P., Bernasconi, E., Weber, R., Hirschel, B., Battegay, M. and Kaufmann, G. R. (2008). CD4+ T cell count recovery in HIV type 1–infected patients is independent of class of antiretroviral therapy. Clinical infectious diseases 47(8): 1093-1101.
  16. Khanna, N., Widmer, A. F., Decker, M., Steffen, I., Halter, J., Heim, D., Weisser, M., Gratwohl, A., Fluckiger, U. and Hirsch, H. H. (2008). Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. Clin Infect Dis 46(3): 402-412.
  17. Khanna, N. and Hirsch, H. H. (2008). Respiratory syncytial virus infection in immunocompromised patients revisited. Clinical infectious diseases 46(12): 1934-1935.
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.